Saint Andrew's Society

Associa EMB Management Volunteers Help Animal Rescue Relocate To New Facility

Retrieved on: 
Lunedì, Giugno 12, 2023
Volunteering, Bravely Default II, EMB, Saint Andrew's Society, Hope, Rehabilitation, Organization, Running, Animal, Love, Pet, Humane society, Seattle metropolitan area

REDMOND, Wash., June 12, 2023 (GLOBE NEWSWIRE) -- Associa EMB Management (EMB) a leading provider of community management services throughout the Metro Seattle, Eastside, and Puget Sound areas and surrounding communities, volunteered with Motley Zoo Animal Rescue to help get their new facility up and running.

Key Points: 
  • REDMOND, Wash., June 12, 2023 (GLOBE NEWSWIRE) -- Associa EMB Management (EMB) a leading provider of community management services throughout the Metro Seattle, Eastside, and Puget Sound areas and surrounding communities, volunteered with Motley Zoo Animal Rescue to help get their new facility up and running.
  • EMB volunteers helped clean up the facility by installing fencing, raking leaves, and spreading gravel throughout a meet-and-greet area for pets and their adoptive parents.
  • Motley Zoo Animal Rescue is dedicated to improving the lives of animals locally, nationally, and internationally.
  • It advocates for all animal life in the hope of ending animal neglect and abuse and to end the devastating effects of pet overpopulation through spaying and neutering.

Crinetics to Highlight Broad Pipeline at ENDO 2023

Retrieved on: 
Venerdì, Giugno 9, 2023
ENDO, Entrepreneurship, Maintenance, Endocrinology, Endocrine system, TSHR, Peptide hormone, FISU World University Games, Policy, Foot, Hyperparathyroidism, Saint Andrew's Society, Acromegaly, PTH1R, Physician, Pharmacokinetics, SAN, Endocrine Society, Primary hyperparathyroidism, Neuroendocrinology, Drug discovery, Medical school, Liver, SST2, Graves' ophthalmopathy, Hyperthyroidism, Memory, Pharmaceutical industry, Vaccine, Medical imaging, Safety

SAN DIEGO, June 09, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced upcoming presentations that will highlight the company’s pipeline at ENDO 2023, the Endocrine Society’s annual meeting, which is being held June 15-18, 2023 in Chicago, Illinois.

Key Points: 
  • SAN DIEGO, June 09, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced upcoming presentations that will highlight the company’s pipeline at ENDO 2023, the Endocrine Society’s annual meeting, which is being held June 15-18, 2023 in Chicago, Illinois.
  • An upcoming oral presentation will review previously reported two-year data from the company’s ACROBAT Advance open-label extension study of paltusotine in acromegaly.
  • I would like to thank the Endocrine Society for awarding this prize, which is a testament to all of the groundbreaking work being done by the Crinetics team.”
    The posters and oral presentations will be made available on the Crinetics website in accordance with the ENDO embargo policy.
  • For attendees of ENDO 2023, Crinetics staff will be available to address questions and discuss pipeline programs at the company booth (#1623).

BridgeBio Pharma to Present Updated Six Month Results from its Phase 2 Cohort 5 Study of Infigratinib in Achondroplasia in a Late Breaker Oral Presentation at the Endocrine Society (ENDO) 2023 Annual Conference

Retrieved on: 
Giovedì, Giugno 8, 2023
ENDO, FGFR, Achondroplasia, Cohort, PALO, Hypoparathyroidism, Saint Andrew's Society, Research, Murdoch, Cancer, Endocrine Society, Conference, PROPEL, Hypochondroplasia, Autosome, Pharmaceutical industry, Paint, Nightclub, Rare-earth element

PALO ALTO, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced today that the updated six month results from Cohort 5 in PROPEL2, a Phase 2 trial of the investigational therapy, infigratinib in children with achondroplasia will be featured in an oral presentation at the Endocrine Society (ENDO) 2023 Annual Conference, taking place in Chicago, Illinois on June 15 – 18, 2023.

Key Points: 
  • PALO ALTO, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced today that the updated six month results from Cohort 5 in PROPEL2, a Phase 2 trial of the investigational therapy, infigratinib in children with achondroplasia will be featured in an oral presentation at the Endocrine Society (ENDO) 2023 Annual Conference, taking place in Chicago, Illinois on June 15 – 18, 2023.
  • At ENDO 2023, BridgeBio will also present additional data from its achondroplasia program and nonclinical results from studies in hypochondroplasia.
  • Furthermore, the Company will share updates from its autosomal dominant hypocalcemia type 1 (ADH1) program, including 18 month data from its ongoing Phase 2 study of encaleret in ADH1 and its sponsored hypoparathyroidism genetic testing program.
  • To access the oral presentation and poster materials following the Company’s participation at ENDO 2023, please visit https://investor.bridgebio.com/presentations .

Associa Principal Management Group Of Houston Volunteers Help Feed The Hungry

Retrieved on: 
Giovedì, Giugno 8, 2023
Houston Metro, Saint Andrew's Society, Organization, HFB, Houston Food Bank, Food, Humane society, Bravely Default II, Tourism

HOUSTON, June 08, 2023 (GLOBE NEWSWIRE) -- Associa Principal Management Group of Houston (PMGH) , a leading provider of community management services throughout the Houston Metro, Katy, The Woodlands, Spring and Conroe areas, recently volunteered with the Houston Food Bank (HFB) to help those in need.

Key Points: 
  • HOUSTON, June 08, 2023 (GLOBE NEWSWIRE) -- Associa Principal Management Group of Houston (PMGH) , a leading provider of community management services throughout the Houston Metro, Katy, The Woodlands, Spring and Conroe areas, recently volunteered with the Houston Food Bank (HFB) to help those in need.
  • Team members helped sort, bag and prepare five large pallets of rice that were distributed to help feed homeless and at-risk families and individuals.
  • In addition, we also provide programs and services aimed at helping families achieve long-term stability including nutrition education, health management, and help in securing state-funded assistance.
  • “Too many residents of southeast Texas lack consistent access to healthy food resources,” said Associa Principal Management Group of Houston Branch Vice President Surina Wright, CMCA®, AMS®, PCAM®.

Community Management Corporation Of New Jersey Helps Feed Those In Need

Retrieved on: 
Mercoledì, Giugno 7, 2023
Food, Fulfillment, Bravely Default II, CMC, Saint Andrew's Society, Organization, Humane society, Hunger, Food security, Tourism, Central Jersey, Neptune

FAIRFIELD, N.J., June 07, 2023 (GLOBE NEWSWIRE) -- Associa Community Management Corporation of New Jersey (CMC-NJ) , a leading provider of community management services throughout the greater Northern and Central New Jersey areas, recently volunteered with the Fulfill food bank in Neptune to help local residents in need.

Key Points: 
  • FAIRFIELD, N.J., June 07, 2023 (GLOBE NEWSWIRE) -- Associa Community Management Corporation of New Jersey (CMC-NJ) , a leading provider of community management services throughout the greater Northern and Central New Jersey areas, recently volunteered with the Fulfill food bank in Neptune to help local residents in need.
  • CMC-NJ team members spent part of their day distributing food from the organization’s warehouse to more than 250 individuals and families.
  • The organization has a network of 289 food pantries, soup kitchens, shelters, day programs, and group homes through which it works to help those in need.
  • “The first event sorted and packed food; the second completed the cycle when it was delivered to the community.”

Kramer-Triad Management Group Plants Wildflowers To Benefit Environment And Beautify Community

Retrieved on: 
Martedì, Giugno 6, 2023
Pollination, Human, Bravely Default II, Bee, Seed, KT, Saint Andrew's Society, Tree, Flower, Pollen, Vegetable, Organization, Object Management Group, Growth, Ecosystem, Humane society, Environment, Agriculture

Team members planted wildflower seeds in plastic cups that were later replanted outdoors to help the environment maintain a habitat conducive to bee pollination.

Key Points: 
  • Team members planted wildflower seeds in plastic cups that were later replanted outdoors to help the environment maintain a habitat conducive to bee pollination.
  • Pollination is the process of transferring tiny grains of pollen from plant to plant, helping flowers grow.
  • Although considered a nuisance by many, bees are a key source of pollination from which approximately one-third of the nation’s crops benefit.
  • “In addition to wildflowers playing a surprisingly important role in our environment, they help provide a pleasant, natural look to the communities we serve.”

Sparrow Pharmaceuticals to Present on HSD-1 Inhibitor SPI-62 at Endocrine Society 2023 Annual Conference

Retrieved on: 
Giovedì, Giugno 8, 2023
Health, Other Health, General Health, Research, Science, Pharmaceutical, Biotechnology, ENDO, Prednisolone, Endocrinology, FRCP, University, Polymyalgia rheumatica, Sparrow, University of Leeds, Cortisol, Saint Andrew's Society, Brain, Doctor of Philosophy, Medication, MD, Rheumatology, Endocrine Society, Disease, Conference, Pharmaceutical industry, Fellow of the Academy of Medical Sciences

Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, will present the rationale that its lead candidate and HSD-1 inhibitor, SPI-62, is predicted to be associated with limited adrenal insufficiency risk in Cushing’s syndrome during a poster session at the Endocrine Society (ENDO) 2023 Annual Conference .

Key Points: 
  • Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, will present the rationale that its lead candidate and HSD-1 inhibitor, SPI-62, is predicted to be associated with limited adrenal insufficiency risk in Cushing’s syndrome during a poster session at the Endocrine Society (ENDO) 2023 Annual Conference .
  • The meeting will be held in-person from June 15-18, 2023 in Chicago, IL.
  • Presentation title: Intracellular Cortisol Control: An Approach to Reduce Cushing’s Syndrome Morbidity With Minimal Adrenal Insufficiency Risk?
  • To learn more about Sparrow Pharmaceuticals SPI-62, visit www.sparrowpharma.com .

Conduent Publishes 2022 Corporate Social Responsibility Report

Retrieved on: 
Lunedì, Giugno 5, 2023
Task Force on Climate Related Financial Disclosures, Gender equality, Saint Andrew's Society, United Nations, Corporate social responsibility, Sustainability Accounting Standards Board, City, 3D, Disclosure, Refund, TCFD, CSR, Conduent, Sustainable Development Goals, Wheelchair, Organization, Task force, Report, Sustainability accounting, Climate change, Guideline, Community, Government agency, Biophysical environment, Growth, ESG, United, PARK, Renewable energy, Social

FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, today published its 2022 Corporate Social Responsibility (CSR) report, which outlines the company’s enterprise-wide Environmental, Social, and Governance (ESG) program. The report highlights Conduent’s initiatives to conduct business ethically, responsibly and sustainably to better serve its stakeholders.

Key Points: 
  • Progress made across environmental, social and governance initiatives through Conduent’s people, technology and solutions
    Report aligns with widely recognized external frameworks, including United Nations Sustainability Development Goals, Task Force on Climate Related Financial Disclosures (TCFD), and Sustainability Accounting Standards Board (SASB) Reporting Framework
    FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, today published its 2022 Corporate Social Responsibility (CSR) report , which outlines the company’s enterprise-wide Environmental, Social, and Governance (ESG) program.
  • The report highlights Conduent’s initiatives to conduct business ethically, responsibly and sustainably to better serve its stakeholders.
  • “Our ESG initiatives are aligned and integrated with our company strategy to drive growth, efficiency and quality.
  • To access the complete Conduent 2022 Corporate Social Responsibility Report, visit https://www.conduent.com/corporate-social-responsibility/ .

Horizon Therapeutics plc Announces Data from the TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low CAS Thyroid Eye Disease (TED) to be Presented at the Upcoming Endocrine Society (ENDO) Annual Meeting

Retrieved on: 
Lunedì, Giugno 5, 2023
Health, Hospitals, Clinical Trials, General Health, Pharmaceutical, Optical, ENDO, Teprotumumab, Exophthalmos, CT, Graves' ophthalmopathy, Safety, OPTIC, Epidemiology, FACP, FACE, Convention, Saint Andrew's Society, Medicine, ECNU, National Primate Research Exhibition Hall, Randomness, Endocrine Society, Diagnosis, Patient, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Treatment, Food, Duke University Health System, TED, Pharmaceutical industry

Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data will be presented at the annual meeting of the Endocrine Society (ENDO 2023) in Chicago, June 15-18.

Key Points: 
  • Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data will be presented at the annual meeting of the Endocrine Society (ENDO 2023) in Chicago, June 15-18.
  • TEPEZZA is the first and only medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of Thyroid Eye Disease (TED) regardless of disease activity or duration.
  • Additionally, two people living with TED will join Malini Gupta, M.D., ECNU, FACE, Director of G2Endo, for a discussion on their journey to diagnosis and experience being treated with TEPEZZA.
  • “The ENDO meeting provides an important opportunity to share results from the TEPEZZA Phase 4 clinical trial, which met its primary endpoint and demonstrated significant proptosis improvement in people who have lived with Thyroid Eye Disease for many years and have low disease activity.”

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

Retrieved on: 
Mercoledì, Maggio 31, 2023
ENDO, Endocrine Society, Abstract, McCormick, Female, Saint Andrew's Society, News, SAN, Pharmaceutical industry, Phosphorus, Auction

SAN JOSE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that three submitted abstracts were accepted for poster presentations at the 105th annual meeting of The Endocrine Society (ENDO 2023) taking place June 15-18, 2023, in Chicago, Illinois.

Key Points: 
  • SAN JOSE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that three submitted abstracts were accepted for poster presentations at the 105th annual meeting of The Endocrine Society (ENDO 2023) taking place June 15-18, 2023, in Chicago, Illinois.
  • The first of Rani’s abstracts noted below will be featured in a news conference hosted by the Endocrine Society from 9-10 am C.T.
  • on June 17, 2023 in Room W-186B in McCormick Place’s West Building.
  • News Feature: This abstract will be featured in a news conference hosted by the Endocrine Society.